Form 4: HashiCorp CTO Armon Dadgar Reports Stock Sale and Trust Transactions

Sentiment:

SEC Form 4 Filing


HashiCorp's Chief Technology Officer, Armon Dadgar, reported the sale of 35,904 shares of Class A Common Stock and transactions involving shares held in trusts and an LLC.

Summary

  • On October 22, 2024, Armon Dadgar, the Chief Technology Officer of HashiCorp, Inc., reported a transaction involving the sale of 35,904 shares of Class A Common Stock at a price of $33.8202 per share.
  • The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 7, 2023.
  • Following the reported transaction, Dadgar directly owns 27,275 shares of Class A Common Stock.
  • Dadgar also indirectly owns a significant number of shares through the Armon Dadgar 2020 Charitable Trust (1,520,000 Class A Common Stock), the Armon Memaran-Dadgar Living Trust (282,617 Class A Common Stock), and Black Swan III, LLC (90,440 Class A Common Stock).
  • Additionally, Dadgar indirectly holds 12,159,372 shares of Class B Common Stock through the Armon Dadgar 2020 Charitable Trust, 2,057,036 shares through the Armon Memaran-Dadgar Living Trust, and 601,328 shares through Black Swan III, LLC.
  • Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider and is a common occurrence for publicly traded companies. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

  • The stock sale by a key executive could be perceived negatively by some shareholders, but the existence of a pre-arranged trading plan mitigates concerns about opportunistic trading.

Key Dates

DateDescription
09/07/2023Date of adoption of Rule 10b5-1 trading plan
10/22/2024Date of stock sale and trust transactions
10/23/2024Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.